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Abstract
Introduction: Osteogenesis imperfecta (OI) is a clinically and genetically heterogeneous disease with skeletal fragility
and variable extra-skeletal manifestations. To date several point mutations in 18 different genes causing different
types of OI have been identified. Mutations in WNT1 compromise activity of the osteoblasts leading to disturbed
bone mass accrual, fragility fractures and progressive skeletal abnormalities. The present study was conducted to
determine the underlying genetic cause of an autosomal recessive skeletal dysplasia in a large consanguineous
family from Chinute, Pakistan.
Materials and methods: Blood was collected from 24 individuals of affected family along with clinical data.
Homozygosity mapping was performed to confirm consanguinity. SNPs were identified, followed by whole exome
and Sanger sequencing. In silico characterization of WNT1 mutation was performed using multiple platforms.
Results: Nine affected family members exhibited severe bone deformities, recurrent fractures, short stature and low
bone mineral density. SNP array data revealed homozygous segments > 1 Mb in length accounting for 2.1–12.7% of
the genome in affected individuals and their siblings and a single 6,344,821 bp homozygous region in all affected
individuals on chromosome 12q12-q13. This region includes two potential OI candidate genes WNT1 and VDR. We
did whole-exome sequencing for both genes in two patients and identified a novel damaging missense mutation
in exon 4 of WNT1: c.1168G > T (NM_005430) resulting in p.G324C. Sanger sequencing confirmed segregation of
mutation with the disease in family.
Conclusion: We report a novel mutation responsible for OI and our investigation expands the spectrum of disease-
causing WNT1 mutations and the resulting OI phenotypes.
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Introduction
Osteogenesis imperfecta (OI) is a genetic disorder with se-
vere bone abnormalities and is the most common form of
primary osteoporosis in children [1]. Clinical phenotype
may vary from prenatal lethal forms to milder forms with
only a few fractures during life time. Severely deforming
forms may have lifelong bone fractures along with visible
skeletal deformities, short stature, dentinogenesis imper-
fecta, blue sclerae, and hearing loss [2]. The incidence of
OI is approximately 1 in 15,000–20,000 live births and
most cases (~ 90%) follow an autosomal dominant pattern
of inheritance with mutations in either COL1A1(MIM
120150) or COL1A2 (MIM 120160) [1]. Rest of the 10%
cases follow the autosomal recessive pattern of inheritance
with mutations in FKBP10, P3H1, LEPRE1, PLOD2, PPIB,
SERPINF1, SERPINH1, SP7, BMP1, TMEM38B, CRTAP,
CREB3L1, IFITM5 and/or WNT1. LRP5 gene may follow
any of the autosomal dominant or recessive patterns;
PLS3 gene follows x-linked mode of inheritance [3–7].
Most of these genetic defects induce a qualitative or quan-
titative change in type I collagen, the main structural pro-
tein in the skeleton. Impaired bone-matrix formation and
mineralization ultimately devastate the skeletal flexibility
and integrity [8]. WNT1 (MIM 164820) has an integral
role in osteoblast differentiation and is involved in the
regulation of the WNT induced beta-catenin signaling
pathway. Biallelic defects in WNT1 result in decreased ex-
pression of type I collagen [1]. Mutations encoding other
components of the signaling pathway have been reported
also in other disorders with abnormal bone mass, suggest-
ing that the pathway has an integral role in the regulation
of bone homeostasis [8].Only a few cases of OI caused by
WNT1 mutations have been described thus far and the
spectrum of clinical manifestations remains inadequately
characterized. Here we present a large consanguineous
Pakistani family in which several family members present
with severe deforming OI caused by a novel homozygous
mutation in WNT1. Wnt1-related osteogenesis imperfecta
has symptoms including scoliosis, developmental delay
and short stature. WNT1 (Wnt Family Member 1) is an
important gene associated with Osteogenesis Imperfecta.
Material and methods
Subjects
We identified a large consanguineous Pakistani family
with multiple family members affected by severe bone
deforming OI. Blood samples for genetic analyses were
collected from all available family members after in-
formed consent. A pedigree was constructed to draw the
relationships and the disease status.
Ethics, consent and permission to publish
This study was approved by the institutional review board
of the Institute of Biomedical and Genetic Engineering
(IBGE), Islamabad, Pakistan. All adult participants gave
written informed consent to participate in this study. For
minors, consent was obtained from their legal guardians /
parents. Permission was also obtained from the patients to
use their data and pictures for publishing.
Phenotypic data
Clinical examination of patients was performed at the
Indoor Patient Department (IPD) of Children’s Hospital
and radiography was done at Radiology Department of
Children’s Hospital, Lahore, Pakistan.
Genotyping
Blood samples were drawn from 24 individuals from the
affected family that included affected (n = 9)and unaffec-
ted(n = 15) individuals. Genomic DNA was extracted
using standard Sambrook protocol [9]. Quality of DNA
was assessed by using Qubit dsDNA HS (High Sensitivity)
Assay kit (Invitrogen) and 24 samples were genotyped on
the IlluminaOmniExpress 24v1–0-A BeadChip array for a
total of 716,503 genetic markers. After removal of single
nucleotide polymorphisms (SNPs) that were mono-
morphic orfailed genotyping in > 1 sample, 392,260
genome-wide SNP markers remained for further analysis.
We confirmed the reported familial relationships among
genotyped samples using PLINK identity by descent (IBD)
analysis (−genome) [10, 11]. We then scanned the data for
large homozygous segments (> 1 Mb) which are shared
among affected individuals but not for the unaffected indi-
viduals. Homozygosity mapping was conducted using
PLINK v1.07 using the default settings [10].
Whole exome sequencing (WES) and sanger sequencing
Targeted enrichment was performed on 1 μg of genomic
DNA from two affected individuals (III:5 and III:15)
using the Nimblegen SeqCap EZ Exome v3 kit and bar-
coded for sequencing on a single lane of a multiplexed
2 × 101 bp sequencing run on the Illumina HiSeq
2000platform. Each individual was sequenced to a mean
coverage of 45.2–46.7 reads per target base, with 97% of
the target exome covered by 10 or more reads. Reads
were mapped using BWA v1.7 [12] and variants were
called using the GATK v2 Unified Genotyper following
the recommended guidelines by GATK ‘Best practices
for variant calling v3’ [13]. We used the following primer
sequences for the segregation of detected mutations in
WNT1 by polymerase chain reaction and Sanger sequen-
cing: WNT1-ForwardGAAATCGCCCAACTTCTGCA
and WNT1-Reverse AGTGCTAGCGAGTCTGTTTGG.
In silico predictions and validation of novel WNT1
mutation G324C
I-Tasser [14, 15] was used for three dimensional (3D)
model predictions. Protein 3D models reliability was
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checked using RAMPAGE server [16]. STITCH4 data-
base [17] was used to predict functional protein part-
ners. Pockets on three-dimensional structures of
proteins were identified using CASTp server [18, 19].
Meta SNP [20] and I-Mutant2.0, were utilized to esti-
mate effect of mutation on stability of protein and to de-
termine whether the mutation has an impact on normal
function of protein or not. Docking analysis was carried
out using PatchDock server [21]. The refinement of first
10 docked complexes obtained through PatchDock was
done using FireDock [22, 23]. Representations (2-Dimen-
sional) and analysis of protein-ligand interaction com-
plexes was done using LIGPLOT [24]. Meta SNP was also
utilized to analyze effect of mutation on protein.
Results
OI phenotype examination
We examined a large consanguineous Pakistani family
with nine affected members (Fig. 1a) diagnosed with OI
type 3 on the basis of apparent clinical features and
radiological findings. All affected individuals manifested
similar features (Additional file 1: Table S1). The two
index patients are described here in more detail.
Patient 1
Patient 1 (III:9) was a 11 years old male, who presented
with a history of multiple fractures after mild trauma since
the age of 6 months. His first fracture of right clavicle oc-
curred at the age of 6 months, followed by fracture of
right tibial shaft at the age of 8 years, and fracture of right
and left femora at 9 years. Pregnancy and birth were un-
eventful. His parents were distant cousins (IBD propor-
tion < 6%). Presently, the index individual is wheelchair
bound because of multiple fractures, deformities and
weakness of lower extremities. His weight is 20 kg, height
106 cm and head circumference 52 cm. Physical examin-
ation revealed brachycephalic head, flat face, mild blueness
of sclerae, right eye squint, short neck, marked thinness of
upper and lower extremities, anterior angulation of both
femora and right tibia, and flat feet (Fig. 1b). Skeletal ra-
diographs revealed generalized osteopenia, bowing of clav-
icles, compression of thoracic vertebrae, narrowing of
intercostal spaces, and bowing of long bones.
Patient 2
Patient 2(III:15) was a 10 years old male, wheelchair
bound, measuring 18 kg in weight, 107 cm in height and
51 cm in head circumference. Pregnancy and delivery
were uneventful. Parents were also distant cousins (IBD
proportion ~ 6%).His health remained poor since birth.
He was able to walk but never became able to run. At
the age of 8 years he sustained fractures of right hu-
merus and right tibia and femur after trivial traumas
(Fig. 1c). Clinical examination showed triangular face,
normal teeth, right eye squint, normal sclerae, and wide
protruding chest with increased antero-posterior diam-
eter. Extremities were thin and showed bilateral mild an-
gulation of proximal humeri and marked bowing of right
femur. His feet were flat. Radiological examination
showed generalized osteopenia, platyspondyli in all ver-
tebrae, narrowing of inter-costal spaces, globular pelvis,
bowing of distal parts of right tibia and fibula, and mild
bowing of right radius and ulna (Fig. 1d and e).
Molecular analysis
Homozygosity mapping
Homozygous segments of > 1 Mb in length accounted for
2.1–12.7% of the genome in all 9 affected individuals and
their full siblings, confirming that these individuals are the
offspring of consanguineous unions. We identified a single
6,344,821 base pair segment on chromosome 12q12-q13
(chr12:46,084,699-52,429,520) that was homozygous only
in affected individuals (Additional file 2: Table S2). Two
candidate genes for bone density were located in the
homozygous segment, the vitamin D receptor VDR and
the wingless-type integration site family, member 1 WNT1.
Whole exome sequencing and segregation analysis
For identification of causal mutation, we performed whole
exome sequencing analysis in two affected cousins III:5 and
III:15 (Additional file 3: Table S3). A total of 43,494 variants
were found in these two individuals, out of which 29,745
were coding and 13,287 were nonsynonymous, frameshift
or splice site variants in well-annotated transcripts. Of
these, 1319 were rare, either absent or present in less than
1% of all populations in HapMap, 1000 genomes popula-
tions [8] and the NHLBI exome variant server (EVS) data-
bases (URL: http://evs.gs.washington.edu/EVS/). Of these,
20 were homozygous in both affected cousins, 3 resided
within the shared homozygous interval on chromosome 12
and only one was predicted to be damaging and not found
in any of the above SNP databases or the Exome
Aggregation Consortium (ExAC) database. This was identi-
fied as a novel damaging mutation in WNT1 c.1168G >T
(RefSeq NM_005430) resulting in p.Gly324Cys. We subse-
quently Sanger sequenced samples of 24 members of the
family and verified that this mutation segregated perfectly
with the disease (Additional file 4: Figure S1). This muta-
tion has not been reported previously in any of the publica-
tions or online databases including ‘ClinVar’, ‘HGMD(R)’
and ‘ExAC’. No pathogenic mutations were found in
CCNT1 or VDR genes; there was only a synonymous SNP
in VDR gene with no amino acid change.
In silico characterization of WNT1 mutation G324C
To gain insight into the structural implications of the
mutation p.G324C, we modelled the wild type and
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mutant proteins using the online I-Tasser server (Fig. 2a,
b and c) [9]. Models with the best c-score were selected
for further analysis. Interaction sites as predicted by
the CASTp results showed a decrease in available
pockets in case of mutant compared to the wild type,
40 compared to 49, respectively; clearly indicating the
effect of mutation upon the binding capacity of the
protein (Fig. 2d). Meta SNP hires with it different
predictors (PATHER, PhD-SNP, SIFT and SNAP) to
calculate mutation impact on normal protein. Value
Fig. 1 a) Pedigree of the family with osteogenesis imperfecta. Affected individuals are marked with black symbols, arrows indicate patients
whose phenotypes are described in the text. Asterisks indicate individuals whose DNA was not available for the study. II:1 and II:2 are estimated
to be first cousins (IBD proportion ~ 11%). III:3 and III:6 are half-siblings (IBD proportion ~ 21%). b) Patient 1 at age 11 years with severe short
stature, short neck, small thorax and long-bone deformities with marked anterior bowing of the bones. He had slightly blue sclerae and a mild
squint. c) Patient 2 at 10 years was wheel-chair bound and had marked skeletal deformities with anterior angulation of the long bones in lower
limbs. d) Radiographs of Patient 2 at 10 years showing severe osteoporosis with thin ribs, flat vertebrae, and osteopenia of the humeri. e) The
femoral bone modeling was normal but both femurs were significantly bent
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reported under each prediction is given in (Fig. 2e).
All predictors show it as disease causing which valid-
ate our result. Obtained calculated values are inter-
preted as following:
 PANTHER: Between 0 and 1. (If > 0.5 mutation is
predicted Disease)
 PhD-SNP: Between 0 and 1. (If > 0.5 mutation is
predicted Disease)
 SIFT: Positive Value (If > 0.05 mutation is predicted
Neutral)
 SNAP: Output normalized between 0 and 1 (If > 0.5
mutation is predicted Disease)
 Meta-SNP: Between 0 and 1. (If > 0.5 mutation is
predicted Disease)
With maximum score of 0.988, Axin 1 has been se-
lected as ligand for further analysis. It is a component of
the beta-catenin destruction complex required for
regulating catenin beta 1 (CTNNB1) levels through
phosphorylation and ubiquitination, and modulating
Wnt-signaling. It controls dorso ventral patterning via
Fig. 2 a) WNT1 protein’s functional residues that are glycosylated are colored blue while the residues forming disulfide linkages are in yellow and the natural
variants (known mutations) are shown in black. Mutation G to C at position 324 is shown in red. b) Wild type zoomed in at the mutation site, the red residue is
the G324 and the yellow residues to its right and left are C315 and C330 respectively. The blue residue at the side is the N316 which is glycosylated. c) Same
site for the mutated protein. d) Comparison of interaction sites for WNT1 (wild and mutant forms). e) Meta SNP prediction for WNT1 mutation (p.G324C) effect
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two opposing effects; down-regulates CTNNB1 to inhibit
the Wnt signaling pathway and ventralize embryos, but also
dorsalizes embryos by activating a Wnt- independent JNK
signalling pathway. Wnt signalling probably facilitates the
phosphorylation of CTNNB1 and APC by GSK3B and is
likely to function as a tumor suppressor. Ligplot results for
the docking interactions of wild and mutant type WNT1
with ligand AXIN 1 are shown in Fig. 3a and b, respectively.
Residues involved in hydrogen bonding and hydrophobic
interactions are given in Table 1. G324C mutation caused a
huge impact on the normal structure and conformation of
the protein molecule. This can be well observed through
differences in number and position of residues involved in
both types of docking interactions. This is due to the alter-
ation of the interaction site after mutation that affected pro-
tein ligand interaction. As per CASTp predictions, pocket
number 49 and 17 (Fig. 4a) contain maximum residues
which are involved in docking of normal protein with lig-
and while pocket number 12 and 38 (Fig. 4b) contain
residues involved in docking interaction of mutant protein.
The analysis not only identifies active sites in the WNT1
structure but also validates the docking results.
Discussion
By performing homozygosity mapping and whole exome
sequencing, we identified a novel homozygous mutation
Fig. 3 a) 2D Ligplot representation ofdocking interaction of normal WNT1 with AXIN1. b) 2D Ligplot representation ofdocking interaction of
mutant WNT1 with AXIN1. Receptor residues involved in hydrophobic interactions are represented by brick red spoked arcs ( ), hydrogen
bonding shown by green dotted lines ( ). Receptor residues involved in H-bonding are shown in green color. Ligand residues
involved in H-bonding are shown in red color
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in WNT1 as the cause of osteogenic imperfecta in this
large consanguineous family. The novel deleterious mu-
tation segregated with the phenotype and in the homo-
zygous individuals resulted in severe clinical findings
consistent with deforming type 3OI, thereby providing
basis for genetic diagnosis of OI in the family. OI com-
prises multiple heterogeneous skeletal phenotypes and
some forms lead to marked deformities of upper and
lower limbs. To date several biallelic missense and non-
sense mutations in WNT1 have been identified with
multiple overlapping skeletal manifestations (Fig. 5).
The p.G324C mutation is predicted to be damaging to
the WNT1 because it occurs at a highly conserved pos-
ition (Fig. 6). The mutated residue (position 324) is
present on a small α-helix with a number of important
functional residues in the vicinity. Nearby asparagine is
glycosylated while cysteine residues at 315 and 330 form
a disulfide linkage. The glycosylation and the disulfide
linkage are important for protein stability. Therefore, the
mutation at position 324 (Gly to Cys) can be detrimental
to protein stability and therefore, functionality. An adja-
cent cysteine residue (position 325) may well present it-
self for a potential disulfide linkage with the mutated
cysteine residue. On the other hand the mutated cyst-
eine may engage the cystein at 315 instead and compete
for a disulfide linkage with the cysteine at 330. In either
case the protein stability at this site may be effected
which might result in producing a dysfunctional protein.
It is also important to note that two other known muta-
tions at position 177 (Gly to Cys) and 298 (Phe to Cys)
have been implicated to cause OI [8, 25]. The highly
conserved glycine at 177 allow for a compact protein
core while the mutated cysteine may disrupt this critical
protein site [8]. WNT proteins are characterized by a set
of 22 conserved cysteine residues that form the
intra-chain disulfide bridges that maintain the tertiary
Table 1 Summary of residues involved in WNT1 docking interactions (Wild & Mutant)
Receptor/Ligand Hydrogen Bond Interactions Hydrophobic Bond Interactions
Ligand Residues Receptor Residues Ligand Residues Receptor Residues







Arg215, Gln216, Glu217, Arg235,
Thr238, Arg240, Asp244, Arg247,
Pro320, Thr348, Phe349, His350, Val355






Asn29, Ser50, Arg91, Lys94,
Gly312, Arg335
Fig. 4 CASTp Results: Interaction sites containing residues involved in Docking a) Normal WNT1 vs AXIN1. b) Mutant WNT1 vs AXIN1
Kausar et al. Journal of Biomedical Science           (2018) 25:82 Page 7 of 10
Fig. 5 All the published WNT1 mutations associated with recessive OI. Red arrow with red text shows all the stop mutations. Red arrow with blue
text point mutations. Blue wedge represents the duplication or deletions. Yellow wedge shows our novel mutation (Figure is made up to scale)
Fig. 6 Alignment of all the WNT proteins indicating the conserved position of glycine 324 in the WNT family
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protein structure [26]. This suggests that the mutations
involving cysteine residues of WNT1 may have serious
impact on the protein stability and function.
Mutations in WNT1have been associated with extreme
phenotypes of osteoporosis, such as prenatally-onset severe
OI, idiopathic juvenile osteoporosis and pregnancy-associated
osteoporosis, confirming WNT1’s central role in regulation
of bone strength. While biallelic mutations, like in our family,
result in severe deforming OI, heterozygous mutations result
in childhood-onset or early adulthood-onset osteoporosis
with spinal and peripheral fractures, low BMD and low bone
turnover, but normal growth and no deformities. Several mu-
tations have been reported. Our patients with homozygous
WNT1 mutations had severe growth failure and early-onset
skeletal fragility leading to severe deformities and loss of am-
bulation. This skeletal phenotype is consistent with other
cases of OI caused by homozygous WNT1 mutations [27].
No skeletal phenotype was evident in the heterozygous muta-
tion carriers in our family, but no systematic phenotyping
with BMD assessment was performed. None of the reported
patients received bisphosphonate treatment and it remains
unknown whether early-onset therapy would be as efficient
as in type I collagen related OI in improving growth and pre-
venting fractures and deformities.
Conclusion
We report a novel mutation G324C in WNT1 gene re-
sponsible for severe recessively inherited Osteogenesis
Imperfecta. This is being reported for the first time in
Pakistan as well as globally. Our report expands the
phenotypic and genotypic spectrum of WNT1-related OI.
OI is a highly divergent disease with different inheritance
patterns and variable severities and further studies on the
clinical and functional consequences of different WNT1
mutations may provide important insight into the roles of
this gene in bone function and development. Optimal
treatment remains to be established in future studies.
Additional files
Additional file 1: Table S1. Clinical findings in the nine affected family
members with a homozygous WNT1 mutation. The “+” signs indicates
the presence and severity of the symptom and “-” sign indicating the
absence of the symptom. (DOCX 15 kb)
Additional file 2: Table S2. Identification of a single homozygous
segment on chr12 overlapping between all cases and none of the
controls. (DOCX 15 kb)
Additional file 3: Table S3. List of rare homozygous variants in III:5 and
III:15 located within the shared homozygous segment on chr12. (DOCX 13 kb)
Additional file 4: Figure S1. Sanger sequencing results of affected
family. Both parents (II:3 and II:4) (right upper and lower panels) of
Patient 1 were heterozygous carriers, arrows indicate the double peaks
(heterozygosity). Patient 1 (III:9) (left lower panel) result indicates
homozygous change, arrow is indicating the change. While an
unaffected individual (III:11) (left upper panel) showed both correct/wild
type alleles. (DOCX 106 kb)
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